LUNGevity sat down with Patrick Forde, MD (MB, BCH), Associate Professor of Oncology at the Johns Hopkins School of Medicine, to discuss the results of the PACIFIC trial and what it means for the lung cancer survivor community. Dr. Forde is an expert on immunotherapies for lung cancer and has led several global phase 3 immunotherapy clinical trials. Click here to view the recorded webinar discussion between LUNGevity and Dr. Forde.#ClinicalTrials #NonSmallCellLungCancer #RecordedWebinar #CollaborativePartner #Durvalumab #ImmuneCheckpointInhibitors #Patient #PatientAdvocate #2019#LUNGevity
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us